{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T11:12:48Z","timestamp":1788606768937,"version":"build-2803163510"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"36","license":[{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Affiliated Hospital of zunyi Medical University","award":["Hospital Document\u00ef\u00bc\u02c62017\u00ef\u00bc\u2030NO.48"],"award-info":[{"award-number":["Hospital Document\u00ef\u00bc\u02c62017\u00ef\u00bc\u2030NO.48"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9,4]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>\n                      Acquired hemophilia A (AHA) is a rare bleeding disorder characterized by the development of autoantibodies directed against coagulation factor VIII (FVIII). Approximately 50% of cases are idiopathic, while the remaining are associated with autoimmune conditions, malignancies, or infections. To date, there have been no reported cases of AHA secondary to Flavobacterium odoratum (\n                      <jats:italic toggle=\"yes\">Frullania odoratum<\/jats:italic>\n                      ) infection.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>A male patient underwent ureteroscopic lithotripsy with double-J stent placement. Postoperatively, he developed hematuria, a right medial thigh hematoma, fever, and abnormal coagulation parameters, including prolonged activated partial thromboplastin time (APTT).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>\n                      The diagnosis of AHA was confirmed based on prolonged APTT, markedly reduced FVIII:C, and detection of a factor VIII inhibitor. Additionally, the patient had a complicated urinary tract infection caused by multidrug-resistant\n                      <jats:italic toggle=\"yes\">F.odoratum<\/jats:italic>\n                      , which preceded the onset of AHA.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>\n                      Doxycycline was administered to treat the catheter-associated urinary tract infection caused by\n                      <jats:italic toggle=\"yes\">F.odoratum<\/jats:italic>\n                      . Hemostatic control was achieved with activated prothrombin complex concentrate. Immunosuppressive therapy for AHA included dexamethasone and cyclophosphamide.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>At discharge, bleeding had resolved, APTT normalized, FVIII activity returned to normal levels, the FVIII inhibitor was undetectable, and the infection was successfully controlled.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>\n                      AHA is a rare but potentially life-threatening condition. Early recognition, prompt treatment, and identification of underlying triggers are crucial to reducing mortality and improving outcomes. This is the first reported case of AHA associated with\n                      <jats:italic toggle=\"yes\">F. odoratum<\/jats:italic>\n                      infection. Clinicians should consider this pathogen in patients with long-term indwelling urinary catheters who present with unexplained infections or bleeding diatheses.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000050501","type":"journal-article","created":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T11:00:49Z","timestamp":1788606049000},"page":"e50501","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Acquired hemophilia a caused by complicated urinary tract infection due to flavobacterium odoratum"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2458-2300","authenticated-orcid":false,"given":"Di","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Hematology, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of Hematology, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingqiang","family":"Ren","sequence":"additional","affiliation":[{"name":"Department of Hematology, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260905","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1080\/10245332.2017.1319115","article-title":"Acquired hemophilia A: a review of recent data and new therapeutic options.","volume":"22","author":"Franchini","year":"2017","journal-title":"Hematology"},{"key":"R2-20260905","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.2169\/internalmedicine.7517-21","article-title":"Acquired hemophilia A presenting with infectious aortic aneurysms due to an underlying Helicobacter cinaedi infection.","volume":"60","author":"Matsuoka","year":"2021","journal-title":"Intern Med"},{"key":"R3-20260905","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1053\/j.seminhematol.2018.02.004","article-title":"Acquired hemophilia A in older adults: a systematic review of case reports and case series.","volume":"55","author":"Godaert","year":"2018","journal-title":"Semin Hematol"},{"key":"R4-20260905","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1538-7836.2012.04654.x","article-title":"Demographic and clinical characteristics of acquired hemophilia A: results from the European acquired haemophilia registry (EACH2).","volume":"10","author":"Knoebl","year":"2012","journal-title":"J Thromb Haemost"},{"key":"R5-20260905","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/bjh.16128","article-title":"Outcome of CARE: a six-year national registry of acquired haemophilia A in China.","volume":"187","author":"Sun","year":"2019","journal-title":"Br J Haematol"},{"key":"R6-20260905","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/hae.14233","article-title":"Acquired haemophilia A in the postpartum period and risk of relapse in subsequent pregnancies: a systematic literature review.","volume":"27","author":"Dewarrat","year":"2021","journal-title":"Haemophilia"},{"key":"R7-20260905","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/hae.13355","article-title":"Acquired haemophilia in patients with cancer: a systematic and critical literature review.","volume":"24","author":"Napolitano","year":"2018","journal-title":"Haemophilia"},{"key":"R8-20260905","first-page":"486","article-title":"Diagnosis and treatment of urinary tract infections complicated with severe bladder contracture caused by Flavobacterium odoratum: a case report and literature review.","volume":"33","author":"Guoxiao","year":"2018","journal-title":"J Clin Urol"},{"key":"R9-20260905","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s43162-021-00074-9","article-title":"Acquired Hemophilia A (AHA): an underreported, underdiagnosed, and undertreated medical condition.","volume":"34","author":"El Demerdash","year":"2022","journal-title":"Egypt J Intern Med"},{"key":"R10-20260905","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1538-7836.2011.04309.x","article-title":"Management of acquired haemophilia A.","volume":"9","author":"Collins","year":"2011","journal-title":"J Thromb Haemost"},{"key":"R11-20260905","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/jth.15291","article-title":"Acquired hemophilia following administration of a COVID-19 vaccine: a case report.","volume":"19","author":"Radwi","year":"2021","journal-title":"J Thromb Haemost"},{"key":"R12-20260905","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.bjid.2012.06.004","article-title":"Myroides odoratimimus soft tissue infection in an immunocompetent child after a pig bite: a case report and literature review.","volume":"16","author":"Maraki","year":"2012","journal-title":"Braz J Infect Dis"},{"key":"R13-20260905","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.micpath.2015.08.001","article-title":"Infection and pathogenicity of Myroides odoratimimus (NIOCR-12) isolated from the gut of grey mullet (Mugil cephalus Linnaeus, 1758).","volume":"88","author":"Ravindran","year":"2015","journal-title":"Microb Pathog"},{"key":"R14-20260905","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s12223-017-0552-5","article-title":"Recurrent calcaneal ulcer infection caused by a biofilm-producing strain of myroides odoratimimus.","volume":"63","author":"Pompilio","year":"2018","journal-title":"Folia Microbiol (Praha)"},{"key":"R15-20260905","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00438-016-1261-5","article-title":"Genomic analysis of the multidrug-resistant clinical isolate Myroides odoratimimus PR63039.","volume":"292","author":"Hu","year":"2017","journal-title":"Mol Genet Genomics"},{"key":"R16-20260905","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1080\/17843286.2016.1245173","article-title":"Management of fulminant erysipelas and sepsis caused by Myroides odoratimimus: a case report and literature review.","volume":"72","author":"Willems","year":"2017","journal-title":"Acta Clin Belg"},{"key":"R17-20260905","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.medcli.2016.04.011","article-title":"Severe sepsis due to prosthetic joint infection caused by Myroides odoratimimus.","volume":"147","author":"Jover-S\u00e1enz","year":"2016","journal-title":"Med Clin (Barc)"},{"key":"R18-20260905","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1099\/00222615-47-2-183","article-title":"Nosocomial catheter-associated Flavobacterium odoratum bacteremia in cancer patients.","volume":"47","author":"Spanik","year":"1998","journal-title":"J Med Microbiol"},{"key":"R19-20260905","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s11274-013-1257-9","article-title":"Association between plasmid content and antibiotic resistance in Myroides odoratimimus SKS05-GRD isolated from raw chicken meat.","volume":"29","author":"Suganthi","year":"2013","journal-title":"World J Microbiol Biotechnol"},{"key":"R20-20260905","first-page":"75","article-title":"Surgical management of patients with hereditary coagulation factor deficiencies: clinical experience.","volume":"23","author":"Chengyu","year":"2018","journal-title":"J Surg Concepts Pract"},{"key":"R21-20260905","first-page":"1","article-title":"Etiology, clinical manifestations, and diagnosis and treatment of 44 cases of acquired hemophilia A.","volume":"24","author":"Ling","year":"2018","journal-title":"Chin J Thromb Hemost"},{"key":"R22-20260905","first-page":"285","article-title":"Clinical analysis of acquired hemophilia A.","volume":"41","author":"Yun","year":"2018","journal-title":"Int J Blood Transfus Hematol"},{"key":"R23-20260905","first-page":"261","article-title":"Analysis of drug resistance of Flavobacterium odoratum producing MUS-1 carbapenemase.","volume":"37","author":"Shulong","year":"2019","journal-title":"Chin J Clin Lab Sci"},{"key":"R24-20260905","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1182\/blood-2008-03-143586","article-title":"Acquired factor VIII inhibitors.","volume":"112","author":"Franchini","year":"2008","journal-title":"Blood"},{"key":"R25-20260905","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1046\/j.1365-2516.2003.00856.x","article-title":"Treatment of acquired haemophilia with factor eight inhibitor bypassing activity.","volume":"10","author":"Sallah","year":"2004","journal-title":"Haemophilia"},{"key":"R26-20260905","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1055\/s-0032-1315757","article-title":"Acquired inhibitors of coagulation factors: part I: acquired hemophilia A.","volume":"38","author":"Coppola","year":"2012","journal-title":"Semin Thromb Hemost"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050501","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T11:00:52Z","timestamp":1788606052000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050501"}},"subtitle":["A case report and literature review"],"short-title":[],"issued":{"date-parts":[[2026,9,4]]},"references-count":26,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000050501","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,4]]},"assertion":[{"value":"2025-05-17","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}